Skip to main navigation Skip to search Skip to main content

Mortality and mobidity remain high despite captopril and/or valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the VALIANT trial

  • Harvey White
  • , Philip Aylward
  • , Zhen Huang
  • , Anthony Dalby
  • , W Weaver
  • , Stale Barvik
  • , Jose Marin-Neto
  • , Jan Murin
  • , Rolf Nordlander
  • , Wiek van Gilst
  • , Faiez Zannad
  • , John McMurray
  • , Robert Califf
  • , Marc Pfeffer

    Research output: Contribution to journalArticlepeer-review

    95 Citations (Scopus)
    Original languageEnglish
    Article numberCC
    Pages (from-to)3391-3399
    Number of pages9
    JournalCirculation
    Volume112
    Issue number22
    Publication statusPublished - 2005

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this